Branched chain amino acids and metabolic regulation

Chinese Science Bulletin

Volumn 58, Issue 11, 2013, Pages 1228-1235

  Wang, ChunXia ^a   Guo, FeiFan ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

amino acid sensor; branched chain amino acids; diabetes; energy homeostasis; glucose metabolism; lipid metabolism; obesity

Indexed keywords

EID: 84877802993     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-013-5681-x     Document Type: Review

References (78)

1. Wasan K M, Looije N A. Emerging pharmacological approaches to the treatment of obesity. J Pharm Pharm Sci, 2005, 8: 259-271.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27: 1047-1053.
3. Jia W P, Wang C, Jiang S, et al. Characteristics of obesity and its related disorders in China. Biomed Environ Sci, 2010, 23: 4-11.
4. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362: 1090-1101.
5. Fan J G, Farrell G C. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009, 50: 204-210.
6. Hofbauer K G. Molecular pathways to obesity. Int J Obes Relat Metab Disord, 2002, 26(Suppl 2): S18-27.
7. Maejima Y, Iwasaki Y, Yamahara Y, et al. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY), 2011, 3: 1169-1177.
8. Bruhat A, Jousse C, Fafournoux P. Amino acid limitation regulates gene expression. Proc Nutr Soc, 1999, 58: 625-632.
9. Parker B, Noakes M, Luscombe N, et al. Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care, 2002, 25: 425-430.
10. Layman D K, Boileau R A, Erickson D J, et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr, 2003, 133: 411-417.
11. Layman D K, Walker D A. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr, 2006, 136: 319S-323S.
12. Felig P, Marliss E, Cahill G F Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med, 1969, 281: 811-816.
13. Newgard C B, An J, Bain J R, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab, 2009, 9: 311-326.
14. Zhang Y, Guo K, LeBlanc R E, et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes, 2007, 56: 1647-1654.
15. Nairizi A, She P, Vary T C, et al. Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr, 2009, 139: 715-719.
16. 2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab, 2007, 5: 103-114.
17. Cota D, Proulx K, Smith K A, et al. Hypothalamic mTOR signaling regulates food intake. Science, 2006, 312: 927-930.
18. Cheng Y, Meng Q, Wang C, et al. Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes, 2010, 59: 17-25.
19. Cheng Y, Zhang Q, Meng Q, et al. Leucine deprivation stimulates fat loss via increasing CRH expression in the hypothalamus and activating the sympathetic nervous system. Mol Endocrinol, 2011, 25: 1624-1635.
20. Elmquist J K, Coppari R, Balthasar N, et al. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol, 2005, 493: 63-71.
21. Cypess A M, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med, 2009, 360: 1509-1517.
22. Du Y, Meng Q, Zhang Q, et al. Isoleucine or valine deprivation stimulates fat loss via increasing energy expenditure and regulating lipid metabolism in WAT. Amino Acids, 2012, 43: 725-734.
23. She P, Reid T M, Bronson S K, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab, 2007, 6: 181-194.
24. Wang T J, Larson M G, Vasan R S, et al. Metabolite profiles and the risk of developing diabetes. Nat Med, 2011, 17: 448-453.
25. Muto Y, Sato S, Watanabe A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol, 2005, 3: 705-713.
26. Tremblay F, Krebs M, Dombrowski L, et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes, 2005, 54: 2674-2684.
27. Xiao F, Huang Z, Li H, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes, 2011, 60: 746-756.
28. Iwanaka N, Egawa T, Satoubu N, et al. Leucine modulates contraction- and insulin-stimulated glucose transport and upstream signaling events in rat skeletal muscle. J Appl Physiol, 2010, 108: 274-282.
29. Higuchi N, Kato M, Miyazaki M, et al. Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. J Cell Biochem, 2011, 112: 30-38.
30. Meijer A J, Sauerwein H P. Amino acid-dependent signal transduction and insulin sensitivity. Curr Opin Clin Nutr Metab Care, 1999, 2: 207-211.
31. Wek S A, Zhu S, Wek R C. The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol Cell Biol, 1995, 15: 4497-4506.
32. Kilberg M S, Pan Y X, Chen H, et al. Nutritional control of gene expression: How mammalian cells respond to amino acid limitation. Annu Rev Nutr, 2005, 25: 59-85.
33. Karpinski B A, Morle G D, Huggenvik J, et al. Molecular cloning of human CREB-2: An ATF/CREB transcription factor that can negatively regulate transcription from the cAMP response element. Proc Natl Acad Sci USA, 1992, 89: 4820-4824.
34. Vallejo M, Ron D, Miller C P, et al. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA, 1993, 90: 4679-4683.
35. 2alpha/ATF4 pathway. PLoS One, 2010, 5: e15716.
36. Kilberg M S, Shan J, Su N. ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol Metab, 2009, 20: 436-443.
37. 2 phosphorylation. J Biol Chem, 2004, 279: 5288-5297.
38. Harding H P, Novoa I, Zhang Y, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell, 2000, 6: 1099-1108.
39. Masuoka H C, Townes T M. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood, 2002, 99: 736-745.
40. Mohamed H A, Yao W, Fioravante D, et al. cAMP-response elements in Aplysia creb1, creb2, and Ap-uch promoters: Implications for feedback loops modulating long term memory. J Biol Chem, 2005, 280: 27035-27043.
41. Yang X, Matsuda K, Bialek P, et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell, 2004, 117: 387-398.
42. Cao J, Dai D L, Yao L, et al. Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. Mol Cell Biochem, 2012, 364: 115-129.
43. Ohoka N, Yoshii S, Hattori T, et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J, 2005, 24: 1243-1255.
44. Seo J, Fortuno E S, 3rd, Suh J M, et al. Atf4 regulates obesity, glucose homeostasis, and energy expenditure. Diabetes, 2009, 58: 2565-2573.
45. Yoshizawa T, Hinoi E, Jung D Y, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest, 2009, 119: 2807-2817.
46. Kode A, Mosialou I, Silva B C, et al. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis. J Biol Chem, 2012, 287: 8757-8768.
47. Wang C, Huang Z, Du Y, et al. ATF4 regulates lipid metabolism and thermogenesis. Cell Res, 2010, 20: 174-184.
48. Li H, Meng Q, Xiao F, et al. ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis. Biochem J, 2011, 438: 283-289.
49. Wang C, Xia T, Du Y, et al. Effects of ATF4 on PGC1? expression in brown adipose tissue and metabolic responses to cold stress. Metabolism, 2012, doi: 10. 1016/j. metabol. 2012. 07. 017.
50. Wullschleger S, Loewith R, Hall M N. TOR signaling in growth and metabolism. Cell, 2006, 124: 471-484.
51. Inoki K, Corradetti M N, Guan K L. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet, 2005, 37: 19-24.
52. Lynch C J. Role of leucine in the regulation of mTOR by amino acids: Revelations from structure-activity studies. J Nutr, 2001, 131: 861S-865S.
53. Harrington L S, Findlay G M, Gray A, et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol, 2004, 166: 213-223.
54. Carlson C J, White M F, Rondinone C M. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem Biophys Res Commun, 2004, 316: 533-539.
55. Ozes O N, Akca H, Mayo L D, et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA, 2001, 98: 4640-4645.
56. Tremblay F, Brule S, Hee Um S, et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA, 2007, 104: 14056-14061.
57. Draznin B. Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: The two sides of a coin. Diabetes, 2006, 55: 2392-2397.
58. Pederson T M, Kramer D L, Rondinone C M. Serine/threonine phosphorylation of IRS-1 triggers its degradation: Possible regulation by tyrosine phosphorylation. Diabetes, 2001, 50: 24-31.
59. Um S H, Frigerio F, Watanabe M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature, 2004, 431: 200-205.
60. Krebs M, Brunmair B, Brehm A, et al. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes, 2007, 56: 1600-1607.
61. Hardie D G, Ross F A, Hawley S A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol, 2012, 13: 251-262.
62. Hardie D G, Sakamoto K. AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda), 2006, 21: 48-60.
63. Jakobsen S N, Hardie D G, Morrice N, et al. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem, 2001, 276: 46912-46916.
64. Inoki K, Zhu T, Guan K L. TSC2 mediates cellular energy response to control cell growth and survival. Cell, 2003, 115: 577-590.
65. Zhang B B, Zhou G, Li C. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab, 2009, 9: 407-416.
66. Ruderman N, Prentki M. AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome. Nat Rev Drug Discov, 2004, 3: 340-351.
67. Long Y C, Zierath J R. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest, 2006, 116: 1776-1783.
68. Leclerc I, Rutter G A. AMP-activated protein kinase: A new beta-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes, 2004, 53(Suppl 3): S67-74.
69. Harper A E, Benevenga N J, Wohlhueter R M. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev, 1970, 50: 428-558.
70. Gietzen D W, Hao S, Anthony T G. Mechanisms of food intake repression in indispensable amino acid deficiency. Annu Rev Nutr, 2007, 27: 63-78.
71. Leung P M, Rogers Q R. Importance of prepyriform cortex in food-intake response of rats to amino acids. Am J Physiol, 1971, 221: 929-935.
72. Hao S, Ross-Inta C M, Gietzen D W. The sensing of essential amino acid deficiency in the anterior piriform cortex, that requires the uncharged tRNA/GCN2 pathway, is sensitive to wortmannin but not rapamycin. Pharmacol Biochem Behav, 2010, 94: 333-340.
73. Williams G, Bing C, Cai X J, et al. The hypothalamus and the control of energy homeostasis: Different circuits, different purposes. Physiol Behav, 2001, 74: 683-701.
74. Tomaszuk A, Simpson C, Williams G. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res, 1996, 46: 53-58.
75. Shimazu T. The hypothalamus and metabolic regulation, especially hypothalamic regulation of lipid metabolism and its disorder. Tanpakushitsu Kakusan Koso, 1984, 29: 1589-1599.
76. Blouet C, Schwartz G J. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav Brain Res, 2010, 209: 1-12.
77. Cota D, Proulx K, Seeley R J. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology, 2007, 132: 2158-2168.
78. Xia T, Cheng Y, Zhang Q, et al. S6K1 in the central nervous system regulates energy expenditure via MC4R/CRH pathways in response to deprivation of an essential amino acid. Diabetes, 2012, 61: 2461-2471.